Advanced Viral Research Corp (786623) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2005

Advanced Viral Research Corp

CIK: 786623

View differences made from one year to another to evaluate Advanced Viral Research Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Viral Research Corp.


Assess how Advanced Viral Research Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Viral Research Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2006 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Advanced Viral Research Corp provided additional information to their SEC Filing as exhibits

CIK: 786623
Form Type: 10-K Annual Report
Accession Number: 0000950144-06-003030
Submitted to the SEC: Fri Mar 31 2006 3:00:26 PM EST
Accepted by the SEC: Fri Mar 31 2006
Period: Saturday, December 31, 2005
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink: